{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:48:55Z","timestamp":1788191335093,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"PPGPE\/Universidade Franciscana-Probic"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior - Brasil","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.micpath.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T10:27:39Z","timestamp":1552127259000},"page":"178-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Characterisation and anti-biofilm activity of glycerol monolaurate nanocapsules against Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"130","author":[{"given":"Leonardo Quintana Soares","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"de Almeida Vaucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Luehring","family":"Giongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"G\u00fcndel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Christ Vianna","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2019.03.007_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.10-0166","article-title":"Pneumonia due to pseudomonas aeruginosa: Part I: epidemiology, clinical diagnosis, and source","volume":"139","author":"Fujitani","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.micpath.2019.03.007_bib2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1042\/BST20120241","article-title":"Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infection","volume":"40","author":"Brown","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.micpath.2019.03.007_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.mi.49.100195.003431","article-title":"Microbial biofilms","volume":"49","author":"Costerton","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2019.03.007_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","author":"Mah","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2019.03.007_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2019.03.007_bib6","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JB.00858-07","article-title":"The EPS matrix: the \u201chouse of biofilm cells,\u201d","volume":"189","author":"Flemming","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2019.03.007_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tim.2004.11.010","article-title":"Survival strategies of infectious biofilms","volume":"13","author":"Fux","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2019.03.007_bib8","first-page":"1034","article-title":"Evolving concepts in biofilm infections, Cell","volume":"11","author":"Hall-Stoodley","year":"2009","journal-title":"Microbiol."},{"key":"10.1016\/j.micpath.2019.03.007_bib9","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2174\/138161210791792868","article-title":"Biofilms: an extra hurdle for effective antimicrobial therapy","volume":"16","author":"Cos","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.micpath.2019.03.007_bib10","series-title":"Title 21. Food and Drugs. Chapter I. Food and Drug Administration. Subchapter B. Food for Human Consumption. Part 184. Direct Food Substances Affirmed as Generally Recognized as Safe. Subpart B. Listing of Specific Substances Affirmed as GRAS. 21 CFR 184","author":"Code of Federal Regulations","year":"2010"},{"key":"10.1016\/j.micpath.2019.03.007_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/AAC.31.1.27","article-title":"Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides","volume":"31","author":"Thormar","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2019.03.007_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/AAC.01151-09","article-title":"Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus","volume":"54","author":"Strandberg","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2019.03.007_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040350","article-title":"Glycerol monolaurate antibacterial activity in broth and biofilm cultures","volume":"7","author":"Schlievert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2019.03.007_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/AAC.36.3.626","article-title":"Effect of glycerol monolaurate on bacterial growth and toxin production","volume":"36","author":"Schlievert","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2019.03.007_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JB.180.1.182-185.1998","article-title":"Glycerol monolaurate inhibits induction of vancomycin resistance in Enterococcus faecalis","volume":"180","author":"Ruzin","year":"1998","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2019.03.007_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.micpath.2016.05.014","article-title":"Evaluation of antimicrobial activity of glycerol monolaurate nanocapsules against American foulbrood disease agent and toxicity on bees","volume":"97","author":"Lopes","year":"2016","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2019.03.007_bib17","doi-asserted-by":"crossref","first-page":"22296","DOI":"10.3390\/ijms151222296","article-title":"Chitosan improves anti-biofilm efficacy of gentamicin through facilitating antibiotic penetration","volume":"15","author":"Mu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2019.03.007_bib18","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1039\/c2ob25835h","article-title":"Small molecule control of bacterial biofilms","volume":"10","author":"Worthington","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.micpath.2019.03.007_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep03364","article-title":"Chitosan coupling makes microbial biofilms susceptible to antibiotics","volume":"3","author":"Zhang","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2019.03.007_bib20","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/mp500846u","article-title":"Improved biofilm antimicrobial activity of polyethylene glycol conjugated tobramycin compared to tobramycin in pseudomonas aeruginosa biofilms","volume":"12","author":"Du","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2019.03.007_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/adhm.201200278","article-title":"Membrane-directed high bactericidal activity of (gold nanoparticle)-polythiophene composite for niche applications against pathogenic bacteria","volume":"2","author":"Adhikari","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.micpath.2019.03.007_bib22","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/am400044e","article-title":"Citrate-capped silver nanoparticles showing good bactericidal effect against both planktonic and sessile bacteria and a low cytotoxicity to osteoblastic cells","volume":"5","author":"Flores","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.micpath.2019.03.007_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2015.04.028","article-title":"Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections","volume":"209","author":"Baelo","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.micpath.2019.03.007_bib24","doi-asserted-by":"crossref","first-page":"16384","DOI":"10.1021\/am504779t","article-title":"Biocompatible nanocarrier fortified with a dipyridinium-based amphiphile for eradication of biofilm","volume":"6","author":"Goswami","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.micpath.2019.03.007_bib25","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1021\/am402618w","article-title":"Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles","volume":"5","author":"Slomberg","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.micpath.2019.03.007_bib26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.colsurfb.2014.02.032","article-title":"Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa","volume":"116","author":"Hadinoto","year":"2014","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.micpath.2019.03.007_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","article-title":"Lipid and polymer nanoparticles for drug delivery to bacterial biofilms","volume":"190","author":"Forier","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.micpath.2019.03.007_bib28","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1021\/jf104402t","article-title":"Curcumin nanoparticles: preparation, characterization, and antimicrobial study","volume":"59","author":"Bhawana","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.micpath.2019.03.007_bib29","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2019.03.007_bib30","first-page":"69","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","volume":"32","author":"CLSI","year":"2012"},{"key":"10.1016\/j.micpath.2019.03.007_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mimet.2009.04.014","article-title":"Pros and cons of using resazurin staining for quantification of viable Staphylococcus aureus biofilms in a screening assay","volume":"78","author":"Sandberg","year":"2009","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.micpath.2019.03.007_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijantimicag.2008.04.022","article-title":"Automating a 96-well microtitre plate model for Staphylococcus aureus biofilms: an approach to screening of natural antimicrobial compounds","volume":"32","author":"Sandberg","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2019.03.007_bib33","doi-asserted-by":"crossref","first-page":"19434","DOI":"10.3390\/ijms141019434","article-title":"Systematic exploration of natural and synthetic flavonoids for the inhibition of Staphylococcus aureus biofilms","volume":"14","author":"Manner","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2019.03.007_bib34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/651558","article-title":"Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model","volume":"201","author":"Martinez","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2019.03.007_bib35","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/AEM.01013-06","article-title":"Multiparameter assessments to determine the effects of sugars and antimicrobials on a polymicrobial oral biofilm","volume":"72","author":"Yang","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2019.03.007_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.micpath.2019.03.007_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","article-title":"Polymer-based nanocapsules for drug delivery","volume":"385","author":"Mora-Huertas","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2019.03.007_bib38","first-page":"17","article-title":"Caracteriza\u00e7\u00e3o f\u00edsico-qu\u00edmica de nanoemuls\u00f5es cati\u00f4nicas como sistemas de libera\u00e7\u00e3o de oligonucleot\u00eddeos, Acta Farm","volume":"25","author":"Silva","year":"2006","journal-title":"Bonaer"},{"key":"10.1016\/j.micpath.2019.03.007_bib39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1590\/S0100-40422008000500038","article-title":"Development and physicochemical characterization of dexamethasone-loaded polymeric nanocapsule suspensions","volume":"31","author":"Friedrich","year":"2008","journal-title":"Quim. Nova"},{"key":"10.1016\/j.micpath.2019.03.007_bib40","first-page":"163","article-title":"Nanoc\u00e1psulas polim\u00e9ricas secas contendo indometacina: estudo de formula\u00e7\u00e3o e de toler\u00e2ncia gastrintestinal em ratos, Acta Farm","volume":"22","author":"Raffin","year":"2003","journal-title":"Bonaer"},{"key":"10.1016\/j.micpath.2019.03.007_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.colsurfb.2012.06.038","article-title":"Poly(\u03b5-caprolactone), Eudragit\u00ae RS 100 and poly(\u03b5-caprolactone)\/Eudragit\u00ae RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz antiretroviral efavirenz","volume":"102","author":"Seremeta","year":"2013","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.micpath.2019.03.007_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.msec.2014.02.003","article-title":"Novel Pullulan-Eudragit\u00ae S100 blend microparticles for oral delivery of risedronate: formulation, in vitro evaluation and tableting of blend microparticles","volume":"38","author":"De Arce Velasquez","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.micpath.2019.03.007_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1524-475X.2007.00283.x","article-title":"Why chronic wounds will not heal\u202f: a novel hypothesis","volume":"16","author":"Bjarnsholt","year":"2008","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.micpath.2019.03.007_bib44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"H\u00f8iby","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2019.03.007_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcf.2011.11.004","article-title":"Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)-A cause for concern?","volume":"11","author":"Ashish","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.micpath.2019.03.007_bib46","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1023\/A:1012248721523","article-title":"Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density","volume":"18","author":"Mosqueira","year":"2001","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.micpath.2019.03.007_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5507\/bp.2004.029","article-title":"Pharmacokinetics and biodistribution studies of Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques","volume":"148","author":"Reddy","year":"2004","journal-title":"Biomed. Pap. Med. Fac. Univ."},{"key":"10.1016\/j.micpath.2019.03.007_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2011.05.013","article-title":"A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems","volume":"8","author":"Kaminskas","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018318989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018318989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:23:10Z","timestamp":1760109790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018318989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":48,"alternative-id":["S0882401018318989"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2019.03.007","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation and anti-biofilm activity of glycerol monolaurate nanocapsules against Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}